Esther Rajavelu

Stock Analyst at UBS

(0.68)
# 4,004
Out of 5,012 analysts
26
Total ratings
46.15%
Success rate
-22.85%
Average return

Stocks Rated by Esther Rajavelu

Ionis Pharmaceuticals
Aug 12, 2025
Maintains: Neutral
Price Target: $45$46
Current: $68.94
Upside: -33.28%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13$2
Current: $1.07
Upside: +86.92%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70$32
Current: $14.90
Upside: +114.77%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141$215
Current: $459.58
Upside: -53.22%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $29.74
Upside: +145.46%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108$109
Current: $15.02
Upside: +625.70%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $27.31
Upside: +28.16%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174$228
Current: $137.32
Upside: +66.04%
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $36.54
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $17.20
Upside: -24.42%
Initiates: Buy
Price Target: $10
Current: $1.08
Upside: +825.93%